Rein Therapeutics, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Rein Therapeutics, Inc. (RNTX) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $2.40 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-05-09
- Rein Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-03-31 was $2.40M.
- Rein Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was $4.52M, a 204.38% increase year-over-year.
- Rein Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was -$41.44M, a 1013.27% decline year-over-year.
- Rein Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was $5.31M.
- Rein Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$38.91M.
- Rein Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$25.00K, a 100.24% decline from fiscal 2015.
- Rein Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was $10.63M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2018-03-31 | $2.40M 10-Q · filed 2018-05-09 | $6.92M derived: sum of 2 quarters · filed 2018-05-09 | -$34.52M derived: sum of 3 quarters · filed 2018-05-09 | -$29.21M derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-12-31 | $4.52M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$36.92M derived: sum of 2 quarters · filed 2018-04-02 | -$31.61M derived: sum of 3 quarters · filed 2018-04-02 | -$38.91M 10-K · filed 2018-04-02 |
| 2017-09-30 | -$41.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$36.13M derived: sum of 2 quarters · filed 2017-11-09 | -$43.43M 10-Q · filed 2017-11-09 | -$41.95M derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-06-30 | $5.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$1.99M 10-Q · filed 2017-08-10 | -$510.00K derived: sum of 3 quarters · filed 2018-05-09 | $4.03M derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-03-31 | -$7.30M 10-Q · filed 2018-05-09 | -$5.82M derived: sum of 2 quarters · filed 2018-05-09 | -$1.28M derived: sum of 3 quarters · filed 2018-05-09 | |
| 2016-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $6.02M derived: sum of 2 quarters · filed 2018-04-02 | -$25.00K 10-K · filed 2018-04-02 | |
| 2016-09-30 | $4.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$1.51M 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | -$6.05M 10-Q · filed 2017-08-10 | |||
| 2015-12-31 | $10.63M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |